Genentech latest to employ Vernalis' discovery engine
This article was originally published in Scrip
Executive Summary
Vernalis has entered into a drug discovery collaboration with Genentech (Roche) utilising Vernalis' fragment and structure-based drug discovery platform against an undisclosed target.